- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 3/00 - Drugs for disorders of the metabolism
Patent holdings for IPC class A61P 3/00
Total number of patents in this class: 7348
10-year publication summary
|
242
|
392
|
467
|
472
|
565
|
522
|
537
|
499
|
481
|
344
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
282 |
| F. Hoffmann-La Roche AG | 7836 |
58 |
| Takeda Pharmaceutical Company Limited | 2715 |
55 |
| Société des Produits Nestlé S.A. | 10107 |
53 |
| Amicus Therapeutics, Inc. | 354 |
52 |
| Boehringer Ingelheim International GmbH | 4493 |
50 |
| Janssen Pharmaceutica N.V. | 3171 |
49 |
| Bristol-myers Squibb Company | 4729 |
46 |
| Pfizer Inc. | 3384 |
46 |
| The Trustees of the University of Pennsylvania | 4414 |
46 |
| Regeneron Pharmaceuticals, Inc. | 4698 |
41 |
| Novartis AG | 10263 |
39 |
| Modernatx, Inc. | 1291 |
38 |
| The Regents of the University of California | 20720 |
36 |
| Eli Lilly and Company | 4089 |
33 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 870 |
33 |
| Genzyme Corporation | 1369 |
32 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3299 |
32 |
| Amgen Inc. | 4425 |
31 |
| Sanofi | 4293 |
28 |
| Other owners | 6268 |